(Q37482586)

20 August 2017

Hormone profiling, WHO 2010 grading, and AJCC/UICC staging in pancreatic neuroendocrine tumor behavior (English)

1 reference

World Health Organization

20 August 2017

0 references

1 reference

Stefano Serra

4

0 references

Ozgur Mete

Ozgur Mete

3

0 references

Ian D McGilvray

Ian McGilvray

10

0 references

Sylvia L. Asa

Sylvia L Asa

12

0 references

Shereen Ezzat

13

Shereen Ezzat

1 reference

20 August 2017

8

Steven Gallinger

1 reference

20 August 2017

Emilie Morin

1

1 reference

20 August 2017

Sonia Cheng

2

1 reference

20 August 2017

Paula B Araujo

5

1 reference

20 August 2017

Sara Temple

6

1 reference

20 August 2017

Sean Cleary

7

1 reference

20 August 2017

Paul D Greig

9

1 reference

20 August 2017

Alice Wei

11

1 reference

20 August 2017

language of work or name

English

0 references

publication date

6 August 2013

1 reference

20 August 2017

1 reference

20 August 2017

2

1 reference

20 August 2017

5

1 reference

20 August 2017

701-711

1 reference

DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3892801

NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3892801

The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3892801

Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE).

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3892801

Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3892801

Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3892801

TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3892801

Neuroendocrine tumors. Molecular targeted therapy for carcinoid and islet-cell carcinoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3892801

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3892801

Endocrine tumours of the pancreas

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3892801

Endocrine tumours of the gastrointestinal tract. Biotherapy for metastatic endocrine tumours

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3892801

Intention-to-treat analysis: implications for quantitative and qualitative research

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3892801

Prognostic validity of a novel American Joint Committee on Cancer Staging Classification for pancreatic neuroendocrine tumors.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3892801

Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3892801

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3892801

Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization

2 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCAM4.96

Alkaline phosphatase predicts survival in patients with metastatic neuroendocrine tumors

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24403235

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24403235

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Surgery and staging of pancreatic neuroendocrine tumors: a 14-year experience

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24403235

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/CAM4.96

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

24403235

1 reference